Development of the VitalFlow® Magnetic Facial Nerve Stimulator as an Emergency Treatment for Stroke

Emilio Sacristan • Mark Borsody

09:30 - 10:45 | Thursday 10 November 2016 | Maya IV - V


Magnetic stimulation of the facial nerve has been shown to dilate cerebral arteries and increase cerebral blood flow. We began proof-of-concept testing of a magnetic stimulator as an early clinical treatment for stroke in 2010. In 2014 we founded Nervive, Inc., to develop a commercial clinical device we called the VitalFlow stimulator, which is currently undergoing clinical trials under FDA oversight for a PMA approval. The VitalFlow story is presented as a case study in moving discovery from bench to market, and how regulatory and funding considerations influence the R&D process.